Vertigo

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2017-06-05
Clinical Trial Update: A Study To Evaluate The Efficacy And Safety Of Betahistine Mesilate In The Treatment Of Patients With Vertigo Caused By Cerebral Infarction In Posterior Circulation [Phase 4]
A Phase 4 trial evaluating betahistine mesilate for vertigo due to posterior circulation cerebral infarction was withdrawn.